Fosamax Also Used to Treat Slight Bone-Thinning Disorder
Fosamax, the blockbuster osteoporosis drug linked to increased risks of throat cancer and irregular heartbeat, also may be prescribed to treat women with a less-serious and lesser known bone-thinning disease.
Continue →First Fosamax Injury Trial Ends in Mistrial
The first trial involving charges that the osteoporosis drug Fosamax caused a user to develop a severe jaw injury, a case that was being closely watched by many as a possible indicator of how hundreds of other similar lawsuits might progress, has ended in a mistrial.
Continue →Judge Allows Dozens of Fosamax Injury Lawsuits to Go Forward
Merck & Co. was dealt a blow in its defense of the controversial osteoporosis drug Fosamax when a New York City federal judge today denied the company’s motion to dismiss two dozen cases filed by people who claim they suffered jaw injuries and other complications as a result of using the drug.
Continue →First Fosamax Injury Trial Heads to Trial Today in NYC
Trial begins today in the case of a Florida woman who claims taking the osteoporosis drug Fosamax caused her to suffer severe dental and jaw problems.
Continue →Popular Osteoporosis Drug Fosamax May Cause Throat Cancer, Researchers Say
The osteoporosis drug Fosamax, taken by tens of millions of Americans to prevent painful bone fractures caused by the disease, may cause esophageal cancer, according to a prestigious medical journal. In a study published January 2, 2009 in the New England Journal of Medicine, an official from the U.S. Food and Drug Administration said the agency has received 23 reports of the cancer, which targets the esophagus, between October 2005 when Fosamax was released and May 2008. Of those 23 …
Continue →
facebook
rss
twitter